2023 annual financial data
Protara Therapeutics 2023 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -43.61M USD and net income was -40.42M USD.
Operating cash flow was -37.56M USD.
Get free Protara Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -43.61M USD
- Net income
- -40.42M USD
- Operating cash flow
- -37.56M USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Protara Therapeutics financial years